Putting organs into the deep freeze, a scavenger hunt for robots, and a book on race and reproduction
By Sarah Crespi, Angela Saini, Warren Cornwall,
Science Magazine
| 06. 29. 2023
Podcast featuring an interview with Dorothy Roberts by Angela Saini
First up this week on the show, scientists are learning how to “cryopreserve” tissues—from donor kidneys to coral larvae. Contributing Correspondent Warren Cornwall joins host Sarah Crespi to talk about the latest in freezing and thawing technology.
Next up: How much does a robot need to “know” about the world to navigate it? Theophile Gervet, a Ph.D. student at Carnegie Mellon University, discusses a scavenger hunt–style experiment that involves bringing robots to Airbnb rentals.
Finally, as part of our series of books on sex, gender, and science, host Angela Saini interviews author Dorothy Roberts, a professor of law and sociology at the University of Pennsylvania, about her book Killing the Black Body: Race, Reproduction, and the Meaning of Liberty.
[note: interview with Dorothy Roberts begins at 0:27:11.2]
TRANSCRIPT
[music]
0:00:05.7 Sarah Crespi: This is the Science Podcast for June 30th, 2023. I'm Sarah Crespi. First up this week, scientists are learning how to cryopreserve tissues from donor kidneys to coral larvae. Contributing correspondent Warren Cornwall joins me to talk about the latest in freezing...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...